Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference73 articles.
1. El-Osta HE, Kurzrock R. Castleman’s disease: from basic mechanisms to molecular therapeutics. Oncologist. 2011;16(4):497–511.
2. Roca B. Castleman’s disease. A review. AIDS Rev. 2009;11(1):3–7.
3. van Rhee F, Stone K, Szmania S, Barlogie B, Singh Z. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol. 2010;8(7):486–98.
4. Fajgenbaum DC, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017;129(12):1646–57.
5. van Rhee F, Greenway A, Stone K. Treatment of idiopathic Castleman disease. Hematology/Oncol Clinics. 2018;32(1):89–106.